• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

PointClickCare acquires QuickMAR, expanding offerings for seniors and LTPAC

Share:

March 11, 2019

The addition of the medication management technology will give senior living providers and pharmacies more choice and flexibility through a single vendor, the company said.

In yet another example of how the health IT industry is moving to create one-stop-shops for technology services, PointClickCare Technologies, provider of cloud-based software for the long-term, post-acute care and senior living industries, announced today it has acquired QuickMAR, a medication management tool for the LTPAC market.

WHY IT MATTERS
“The objective of the acquisition is to provide senior living providers and pharmacies broader choice and flexibility through one technology vendor for their eMAR and EHR needs,” according to Andy Brigant, vice president of pharmacy sales and program management for PointClickCare.

“PointClickCare’s acquisition of QuickMAR will give the company’s customers and partner pharmacies the flexibility to choose how they want to approach their resident care strategies, while working with a single technology vendor,” said Brigant.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

THE LARGER TREND
Both PointClickCare and QuickMAR enjoy established market positions, according to Brigant. QuickMAR serves approximately 600 pharmacy customers from 3,700 senior living communities. “Combined we will now serve approximately 10,000 senior living providers that care for 67 percent of all residents in assisted living facilities,” he added.

QuickMAR will continue to operate as a separate entity for the foreseeable future, including its platform, according to Brigant. eMAR is a server-based electronic medication administration system designed for use in institutional pharmacies, assisted living, long-term care, and rehab facilities. The software automates the process of distributing, tracking, and re-ordering medications and treatments safely.

PointClickCare and QuickMAR will approach the market in different ways and have complementary approaches to their service model, Brigant says. Providers and pharmacies will have the opportunity to choose the platform and service model that best fits their needs.

As we’ve show in other case studies, integrating medication management with EHRs can have big benefits for providers. That’s the goal for PointClickCare, which has recently been working to innovate its offerings to the LTPAC space, through initiatives such as a self-service developer program that offers APIs to encourage creation of new tools and apps for a space that’s still often underserved by technology.

ON THE RECORD
“The acquisition of QuickMAR expands and strengthens our health and wellness portfolio, provides our customers with more flexibility and choice in medication management solutions, and enables us to service a more diverse set of senior living communities,” said Mike Wessinger, chief executive officer, PointClickCare.

Reed DeMordaunt, CEO and co-founder, QuickMAR, added that the new partnership will “further strengthen our ability to assist senior living and LTPAC providers, and their pharmacy partners, in providing high-quality care to their residents. As our organization enters a new business chapter, our mission will remain the same: to improve medication accuracy and enhance resident safety with cutting-edge technology.”

Date: March 11, 2019

Source: HealthcareIT News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Nimbus Therapeutics Announces Closing of Takeda’s Acquisition of TYK2 SubsidiaryNimbus Therapeutics Announces Closing of Takeda’s Acquisition of TYK2 Subsidiary
  • What The Failure of Microsoft’s HealthVault Means for the Future of EHRsWhat The Failure of Microsoft’s HealthVault Means for the Future of EHRs
  • Digital Health Market Trends, Growth Insights, Research Overview, Regional Outlook, COVID-19 Impact and Global Industry Analysis By 2025Digital Health Market Trends, Growth Insights, Research Overview, Regional Outlook, COVID-19 Impact and Global Industry Analysis By 2025
  • Immunomodulators Market worth USD 285.01 Billion at 6.3% CAGR; Enhancement of Supply Chain to Boost Growth amid COVID-19Immunomodulators Market worth USD 285.01 Billion at 6.3% CAGR; Enhancement of Supply Chain to Boost Growth amid COVID-19
  • Adare Pharma Solutions Acquires Frontida Biopharm to Expand Leading CDMO OfferingsAdare Pharma Solutions Acquires Frontida Biopharm to Expand Leading CDMO Offerings
  • Shockwave Medical Completes Acquisition of NeovascShockwave Medical Completes Acquisition of Neovasc
  • Healthy.io Launches Wound Care Tech in USHealthy.io Launches Wound Care Tech in US
  • Sharecare Creates Free Embeddable COVID-19 Chatbot ScreenerSharecare Creates Free Embeddable COVID-19 Chatbot Screener

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications